[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

WO2008065544A3 - Genetic predictors of risk for type 2 diabetes mellitus - Google Patents

Genetic predictors of risk for type 2 diabetes mellitus Download PDF

Info

Publication number
WO2008065544A3
WO2008065544A3 PCT/IB2007/004361 IB2007004361W WO2008065544A3 WO 2008065544 A3 WO2008065544 A3 WO 2008065544A3 IB 2007004361 W IB2007004361 W IB 2007004361W WO 2008065544 A3 WO2008065544 A3 WO 2008065544A3
Authority
WO
WIPO (PCT)
Prior art keywords
risk
type
diabetes mellitus
t2dm
genetic predictors
Prior art date
Application number
PCT/IB2007/004361
Other languages
French (fr)
Other versions
WO2008065544A2 (en
Inventor
Constantin Polychronakos
Rob Sladek
Philippe Froguel
Original Assignee
Univ Mcgill
Constantin Polychronakos
Rob Sladek
Philippe Froguel
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill, Constantin Polychronakos, Rob Sladek, Philippe Froguel filed Critical Univ Mcgill
Publication of WO2008065544A2 publication Critical patent/WO2008065544A2/en
Publication of WO2008065544A3 publication Critical patent/WO2008065544A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/172—Haplotypes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Methods of analyzing individuals at risk for the development of Type 2 diabetes mellitus (T2DM). Nucleic acids obtained from biological samples of individuals suffering from T2DM have been analyzed and SNPs associated with T2DM genes have been discovered. In addition, SNPs in linkage disequilibrium with T2DM genes are described.
PCT/IB2007/004361 2006-09-11 2007-09-11 Genetic predictors of risk for type 2 diabetes mellitus WO2008065544A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84358606P 2006-09-11 2006-09-11
US60/843,586 2006-09-11

Publications (2)

Publication Number Publication Date
WO2008065544A2 WO2008065544A2 (en) 2008-06-05
WO2008065544A3 true WO2008065544A3 (en) 2009-03-19

Family

ID=39468332

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2007/004361 WO2008065544A2 (en) 2006-09-11 2007-09-11 Genetic predictors of risk for type 2 diabetes mellitus

Country Status (1)

Country Link
WO (1) WO2008065544A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2493916B1 (en) 2009-10-26 2016-06-08 Externautics S.p.A. Lung tumor markers and methods of use thereof
US20130022983A1 (en) 2009-10-26 2013-01-24 Externautics S.P.A. Colon and Rectal Tumor Markers and Methods of Use Thereof
WO2011051280A1 (en) 2009-10-26 2011-05-05 Externautics S.P.A. Ovary tumor markers and methods of use thereof
US10689702B2 (en) 2012-01-27 2020-06-23 The Chinese University Of Hong Kong Biomarkers for diabetes
WO2021178166A1 (en) * 2020-03-06 2021-09-10 Denovo Biopharma Llc Compositions and methods for assessing the efficacy of inhibitors of neurotransmitter transporters

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2847263A1 (en) * 2002-11-18 2004-05-21 Commissariat Energie Atomique New nucleic acid encoding a zinc transporter, useful for diagnosis and treatment of diabetes, also derived proteins, antibodies, transformed cells and organisms, and method for selected islet beta cells
WO2004042358A2 (en) * 2002-11-01 2004-05-21 Decode Genetics Ehf. HUMAN TYPE II DIABETES GENE-SLIT-3 LOCATED ON CHROMOSOME 5q35
US20050147987A1 (en) * 2000-09-08 2005-07-07 Applera Corporation (Ny) Polymorphisms in known genes associated with type II diabetes and obesity, methods of detection and uses thereof
WO2006022634A1 (en) * 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2008065682A2 (en) * 2006-11-30 2008-06-05 Decode Genetics Ehf. Genetic susceptibility variants of type 2 diabetes mellitus

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050147987A1 (en) * 2000-09-08 2005-07-07 Applera Corporation (Ny) Polymorphisms in known genes associated with type II diabetes and obesity, methods of detection and uses thereof
WO2004042358A2 (en) * 2002-11-01 2004-05-21 Decode Genetics Ehf. HUMAN TYPE II DIABETES GENE-SLIT-3 LOCATED ON CHROMOSOME 5q35
FR2847263A1 (en) * 2002-11-18 2004-05-21 Commissariat Energie Atomique New nucleic acid encoding a zinc transporter, useful for diagnosis and treatment of diabetes, also derived proteins, antibodies, transformed cells and organisms, and method for selected islet beta cells
WO2006022634A1 (en) * 2004-07-22 2006-03-02 Sequenom, Inc. Methods for identifying risk of type ii diabetes and treatments thereof
WO2008065682A2 (en) * 2006-11-30 2008-06-05 Decode Genetics Ehf. Genetic susceptibility variants of type 2 diabetes mellitus

Non-Patent Citations (10)

* Cited by examiner, † Cited by third party
Title
DATABASE ENTREZ PROTEIN [online] NCBI; 18 May 2005 (2005-05-18), "CAH72347. Reports calmodulin bindin...[gi:55665770]", XP002497998, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV/ENTREZ/VIEWER.FCGI?DB=PROTEIN Database accession no. 55665770 *
DATABASE ENTREZ PROTEIN [online] NCBI; 7 May 2008 (2008-05-07), "CAH72347. Reports calmodulin bindin...[gi:55665770]", XP002497997, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV/ENTREZ/VIEWER.FCGI?DB=PROTEIN Database accession no. 55665770 *
DATABASE PROBE [online] ncbi; 22 February 2006 (2006-02-22), "rs13266634", XP002509338, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV Database accession no. Pr003758580.1 *
DATABASE SNP [online] NCBI; 10 October 2003 (2003-10-10), "rs1193179", XP002497772, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV Database accession no. rs1193179 *
DATABASE SNP [online] NCBI; 13 September 2004 (2004-09-13), "rs3266634", XP002509337, retrieved from HTTP://WWW.NCBI.NLM.NIH.GOV Database accession no. rs13266634 *
DIABETES GENETICS INITIATIVE OF BROAD INSTITUTE OF HARVARD AND MIT, LUND UNIVERSITY, AND NOVARTIS INSTITUTES OF BIOMEDICAL RESEARC: "Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels.", SCIENCE (NEW YORK, N.Y.) 1 JUN 2007, vol. 316, no. 5829, 1 June 2007 (2007-06-01), pages 1331 - 1336, XP002509336, ISSN: 1095-9203 *
GRANT STRUAN F A ET AL: "Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes", NATURE GENETICS, NATURE PUBLISHING GROUP, NEW YORK, US, vol. 38, no. 3, 1 March 2006 (2006-03-01), pages 320 - 323, XP009096714, ISSN: 1061-4036 *
KANG EUN SEOK ET AL: "The influence of adiponectin gene polymorphism on the rosiglitazone response in patients with type 2 diabetes.", May 2005, DIABETES CARE MAY 2005, VOL. 28, NR. 5, PAGE(S) 1139 - 1144, ISSN: 0149-5992, XP002496473 *
SLADEK ROBERT ET AL: "A genome-wide association study identifies novel risk loci for type 2 diabetes", NATURE, NATURE PUBLISHING GROUP, LONDON, UK, vol. 445, no. 7130, 22 February 2007 (2007-02-22), pages 881 - 885, XP002465137, ISSN: 0028-0836 *
STEPHANE CAUCHI ET AL: "Analysis of novel risk loci for type 2 diabetes in a general French population: the D.E.S.I.R. study", 22 January 2008, JOURNAL OF MOLECULAR MEDICINE, SPRINGER, BERLIN, DE, PAGE(S) 341 - 348, ISSN: 1432-1440, XP019576423 *

Also Published As

Publication number Publication date
WO2008065544A2 (en) 2008-06-05

Similar Documents

Publication Publication Date Title
WO2006134154A3 (en) Enpp1 (pc-1) gene haplotype associated with the risk of obesity and type 2 diabetes and their applications
WO2007103808A3 (en) Microrna expression profile associated with pancreatic cancer
WO2007038670A3 (en) Methods and compositions for screening and treatment of disorders of blood glucose regulation
WO2007146819A3 (en) Methods for identifying and using snp panels
WO2008048119A3 (en) Methods of analysis of polymorphisms and uses thereof
WO2008122670A3 (en) Human diabetes susceptibility tnfrsf10b gene
WO2007070280A3 (en) Use of deletion polymorphisms to predict, prevent, and manage histoincompatibility
WO2009059317A3 (en) Predicting amd with snps within or near c2, factor b, plekha1, htra1, prelp, or loc387715
WO2007034221A3 (en) Non small cell lung cancer therapy prognosis and target
WO2003012046A3 (en) Stk15 (stk6) gene polymorphism and methods of determining cancer risk
WO2004046098A3 (en) Method for predicting autoimmune diseases
SG134283A1 (en) Biomarkers for liver fibrotic injury
WO2006127294A3 (en) Methods for diagnosis or prognosis of late age onset disease
WO2006063704A3 (en) Single nucleotide polymorphism (snp) associated to type ii diabetes
WO2008065544A3 (en) Genetic predictors of risk for type 2 diabetes mellitus
WO2005087953A8 (en) Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
WO2006110748A3 (en) Response gene to complement 32 (rgc-32) in disease
WO2006099259A3 (en) Novel missense mutations and single nucleotide polymorphisms in the rabphillin-3a-like gene and uses thereof
GB0500996D0 (en) Detection method and materials therefor
WO2008065682A3 (en) Genetic susceptibility variants of type 2 diabetes mellitus
WO2005034737A3 (en) Methods for diagnosing and treating endoplasmic reticulum (er) stress diseases
WO2004035741A3 (en) Susceptibility gene for myocardial infarction; methods of treatment
WO2010030167A3 (en) Method of detection and diagnosis of oral and nasopharyngeal cancers
WO2010009440A3 (en) Non-invasive fetal rhd genotyping from maternal whole blood
WO2006022619A3 (en) Methods for identifying risk of type ii diabetes and treatments thereof

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07866630

Country of ref document: EP

Kind code of ref document: A2